Related Experiment Video
Updated: Feb 16, 2026

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
Published on: November 8, 2016
Regulatory T Cells: From Discovery to Autoimmunity
Alexandra Kitz1, Emily Singer1, David Hafler1
1Departments of Neurology and Immunobiology, Yale School of Medicine, New Haven, Connecticut 06520.
Abstract:
Multiple sclerosis (MS) is a genetically mediated autoimmune disease of the central nervous system. Allelic variants lead to lower thresholds of T-cell activation resulting in activation of autoreactive T cells. Environmental factors, including, among others, diet, vitamin D, and smoking, in combination with genetic predispositions, play a substantial role in disease development and activation of autoreactive T cells. FoxP3+ regulatory T cells (Tregs) have emerged as central in the control of autoreactive T cells. A consistent finding in patients with MS is defects in Treg cell function with reduced suppression of effector T cells and production of proinflammatory cytokines. Emerging data suggests that functional Tregs become effector-like T cells with loss of function associated with T-bet expression and interferon γ (IFN-γ) secretion.
Related Concept Videos
Cis-regulatory Sequences
Cis-regulatory Sequences
Drug Discovery: Overview
Global Regulatory Systems
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

